Effective 5/14/2019
49-20-419. Coverage of exome sequence testing.
49-20-419. Coverage of exome sequence testing.
- (1) As used in this section, “exome sequence testing” means a genomic technique for sequencing the genome of an individual for diagnostic purposes.
- (2) Beginning July 1, 2019, the program shall provide coverage for exome sequence testing:
- (a) for a covered individual within the state risk pool who:
- (i) is younger than 21 years of age; and
- (ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related tests;
- (b) performed by a nationally recognized provider with significant experience in exome sequence testing;
- (c) that is medically necessary; and
- (d) at a rate set by the program.
- (a) for a covered individual within the state risk pool who:
Enacted by Chapter 320, 2019 General Session